Robert T Abraham Selected Research

Robert T Abraham Research Topics

Disease

42	Neoplasms (Cancer) 01/2021 - 03/2002
6	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2005
6	Hypoxia (Hypoxemia) 01/2010 - 03/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 09/2005
3	Melanoma (Melanoma, Malignant) 07/2015 - 10/2011
2	Hematologic Neoplasms (Hematological Malignancy) 08/2017 - 04/2008
2	Carcinogenesis 07/2014 - 06/2005
2	Inflammation (Inflammations) 07/2014 - 05/2010
2	Starvation 10/2010 - 05/2010
2	Tuberous Sclerosis (Bourneville's Disease) 05/2010 - 01/2009
2	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2004 - 01/2002
1	Parkinson Disease (Parkinson's Disease) 03/2017
1	Liposarcoma 07/2015
1	Retinoblastoma (Glioblastoma, Retinal) 07/2015
1	Obesity 07/2014
1	Tics (Tic) 01/2013
1	Carcinoma (Carcinomatosis) 11/2011
1	Lung Neoplasms (Lung Cancer) 06/2011
1	Hepatitis B 05/2010
1	Pancreatitis 05/2010
1	Glioma (Gliomas) 01/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2009
1	Osteosarcoma (Osteogenic Sarcoma) 05/2008
1	Head and Neck Neoplasms (Head and Neck Cancer) 02/2008
1	Squamous Cell Carcinoma of Head and Neck 02/2008

Drug/Important Bio-Agent (IBA)

13	TOR Serine-Threonine KinasesIBA 11/2011 - 01/2002
10	Proteins (Proteins, Gene)FDA Link 05/2013 - 03/2002
8	Phosphotransferases (Kinase)IBA 01/2021 - 01/2002
7	Sirolimus (Rapamycin)FDA Link 01/2010 - 10/2002
6	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 08/2009
6	MTOR InhibitorsIBA 01/2010 - 06/2007
4	AntigensIBA 05/2013 - 06/2011
3	Immunoconjugates (Immunoconjugate)IBA 05/2013 - 06/2011
3	Pharmaceutical PreparationsIBA 11/2012 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 11/2011 - 12/2009
3	temsirolimus FDA Link 11/2011 - 04/2008
2	palbociclibIBA 01/2021 - 07/2015
2	Phosphatidylinositols (Phosphatidylinositol)IBA 08/2017 - 01/2010
2	UbiquitinIBA 03/2017 - 01/2006
2	Biological ProductsIBA 05/2013 - 09/2007
2	Serine (L-Serine)FDA Link 10/2011 - 03/2002
2	Glucose (Dextrose)FDA LinkGeneric 05/2010 - 09/2005
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2010 - 08/2009
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2009 - 09/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2008 - 06/2005
2	PX-866IBA 09/2007 - 09/2005
1	Cytostatic AgentsIBA 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	AntiportersIBA 01/2019
1	AntioxidantsIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Cystine (L-Cystine)IBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	idelalisibIBA 08/2017
1	Protein Isoforms (Isoforms)IBA 08/2017
1	Growth Factor ReceptorsIBA 08/2017
1	NexusIBA 03/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2017
1	Chloroquine (Aralen)FDA LinkGeneric 01/2016
1	ribociclibIBA 07/2015
1	abemaciclibIBA 07/2015
1	CyclinsIBA 07/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2015
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 07/2015
1	Cyclin DIBA 07/2015
1	Beclin-1IBA 09/2013
1	Explosive Agents (Explosives)IBA 05/2013
1	A1mcMMAFIBA 01/2013
1	ChemokinesIBA 12/2012
1	Interleukin-8 (Interleukin 8)IBA 12/2012
1	Dextrans (Dextran)FDA Link 11/2011
1	Tumor Viral Antigens (Large T Antigen)IBA 11/2011
1	Texas redIBA 11/2011
1	PhosphoproteinsIBA 11/2011
1	Amino Acids FDA Link 03/2011
1	NitrogenIBA 03/2011
1	Glutamine (L-Glutamine)FDA Link 03/2011
1	CarbonIBA 03/2011
1	trans-sodium crocetinate (crocetin)IBA 05/2010
1	PPAR gammaIBA 05/2010
1	ethyl pyruvateIBA 05/2010
1	AsbestosIBA 05/2010
1	SteroidsIBA 05/2010
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 03/2010
1	WYE 125132IBA 01/2010
1	Antineoplastic Agents (Antineoplastics)IBA 01/2010
1	Bevacizumab (Avastin)FDA Link 01/2010
1	ChromatinIBA 09/2009
1	CamptothecinIBA 08/2009
1	WYE-354IBA 08/2009
1	Small Interfering RNA (siRNA)IBA 05/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2008

Therapy/Procedure

18	Therapeutics 01/2021 - 08/2002
1	Immunotherapy 01/2019
1	Precision Medicine 05/2014
1	Biological Therapy 05/2010
1	Oral Administration 01/2010